Home/Filings/4/0001437749-23-028657
4//SEC Filing

Fernandez Charles M. 4

Accession 0001437749-23-028657

CIK 0001402945other

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 12:04 PM ET

Size

30.7 KB

Accession

0001437749-23-028657

Insider Transaction Report

Form 4
Period: 2023-07-01
Transactions
  • Exercise of In-Money

    Common Stock

    2023-07-01$2.20/sh+340,599$749,3182,111,241 total(indirect: By NextPlat Corp)
  • Exercise of In-Money

    Common Stock

    2023-07-01$2.20/sh+228,240$502,1281,557,356 total(indirect: By LLC)
  • Exercise of In-Money

    Common Stock Warrant

    2023-07-01+228,2400 total(indirect: By LLC)
    Exercise: $2.20From: 2023-05-09Exp: 2028-05-09Common Stock (228,240 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2023-07-01+340,5990 total(indirect: By NextPlat Corp)
    Exercise: $2.20From: 2023-05-09Exp: 2026-05-09Common Stock (340,599 underlying)
  • Exercise of In-Money

    Common Stock

    2023-07-01$2.20/sh+190,000$418,0001,634,518 total(indirect: By LLC)
  • Exercise of In-Money

    Common Stock

    2023-07-01$2.20/sh+455,000$1,001,0001,995,586 total(indirect: By NextPlat Corp)
  • Sale

    Common Stock

    2023-07-01$4.45/sh224,944$1,001,0011,770,642 total(indirect: By NextPlat Corp)
  • Sale

    Common Stock

    2023-07-01$4.45/sh112,838$502,1291,444,518 total(indirect: By LLC)
  • Sale

    Common Stock

    2023-07-01$4.45/sh93,932$417,9971,540,586 total(indirect: By LLC)
  • Sale

    Common Stock

    2023-07-01$4.45/sh168,386$749,3181,942,855 total(indirect: By NextPlat Corp)
  • Exercise of In-Money

    Common Stock Warrant

    2023-07-01+230,0000 total(indirect: By NextPlat Corp)
    Exercise: $2.20From: 2023-05-09Exp: 2028-05-09Common Stock (230,000 underlying)
  • Exercise of In-Money

    Common Stock

    2023-07-01$2.20/sh+230,000$506,0002,172,855 total(indirect: By NextPlat Corp)
  • Exercise of In-Money

    Common Stock Warrant

    2023-07-01+190,0000 total(indirect: By LLC)
    Exercise: $2.20From: 2023-05-09Exp: 2026-05-09Common Stock (190,000 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2023-07-01+455,0000 total(indirect: By NextPlat Corp)
    Exercise: $2.20From: 2023-05-09Exp: 2026-05-09Common Stock (455,000 underlying)
Footnotes (8)
  • [F1]On July 1, 2023, eAperion Partners, LLC exercised a Conversion Warrant to purchase 228,240 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 112,838 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 115,402 shares.
  • [F2]On July 1, 2023, eAperion Partners, LLC exercised an Inducement Warrant to purchase 190,000 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 93,932 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 96,068 shares.
  • [F3]On July 1, 2023, NextPlat Corp exercised a Warrant to purchase 455,000 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 224,944 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 230,056 shares.
  • [F4]On July 1, 2023, NextPlat Corp exercised a Conversion Warrant to purchase 340,599 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 168,386 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,213 shares.
  • [F5]On July 1, 2023, NextPlat Corp, exercised a Conversion Warrant to purchase 230,000 shares of RXMD common stock for $2.20 per share. NextPlat Corp paid the exercise price on a cash basis.
  • [F6]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F7]The Reporting Person is the sole member and managing member of eAperion Partners LLC.
  • [F8]Includes 18,261 shares of common stock directly held by the Reporting Person; 1,071,251 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 239,604 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member.

Issuer

Progressive Care Inc.

CIK 0001402945

Entity typeother

Related Parties

1
  • filerCIK 0001509529

Filing Metadata

Form type
4
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 12:04 PM ET
Size
30.7 KB